Literature DB >> 8642387

Quality of life in peritoneal dialysis patients.

T E Steele1, D Baltimore, S H Finkelstein, P Juergensen, A S Kliger, F O Finkelstein.   

Abstract

In 49 patients receiving continuous ambulatory peritoneal dialysis, we assessed the relative influences of adequacy of dialysis (assessed by kinetic transfer/volume urea) and psychological symptoms (depression and anxiety) upon the patients' evaluation of their overall quality of life (QoL). Subjects completed self-rating forms for anxiety, depressive, and somatic symptoms, for discrete areas relevant to QoL, and for overall QoL; clinicians also rated QoL. Depressive symptoms proved a much stronger correlate of overall QoL than did the biochemical measure of dialysis adequacy, and they remained influential even after adjustment for anxiety, kinetic transfer/volume, and somatic symptoms. In contrast, the effects of kinetic transfer/volume, anxiety symptoms, and somatic symptoms dropped sharply when adjusted for the other variables. Because psychological (especially depressive) symptoms may be stronger determinants of patients' overall QoL than is adequacy of dialysis, assessing QoL and psychological status should be part of the care of end-stage renal disease patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642387     DOI: 10.1097/00005053-199606000-00007

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  13 in total

1.  The SF36 as an outcome measure of services for end stage renal failure.

Authors:  J P Wight; L Edwards; J Brazier; S Walters; J N Payne; C B Brown
Journal:  Qual Health Care       Date:  1998-12

2.  Depression and its 6-month course in untreated hemodialysis patients: a preliminary prospective follow-up study in Turkey.

Authors:  Atilla Soykan; Hamid Boztas; Sim Kutlay; Elmas Ince; Bahire Aygor; Aykut Ozden; Gokhan Nergizoglu; Oguz Berksun
Journal:  Int J Behav Med       Date:  2004

3.  Outcome of patients with reactive amyloidosis associated with rheumatoid arthritis in dialysis treatment.

Authors:  Takeshi Kuroda; Naohito Tanabe; Hiroe Sato; Jyunya Ajiro; Yoko Wada; Syuichi Murakami; Hisashi Hasegawa; Minoru Sakatsume; Masaaki Nakano; Fumitake Gejyo
Journal:  Rheumatol Int       Date:  2006-09-05       Impact factor: 2.631

4.  Depression as a determinant of quality of life in patients with chronic disease: data from Brazil.

Authors:  Luciane Nascimento Cruz; Marcelo Pio de Almeida Fleck; Carisi Anne Polanczyk
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-09-22       Impact factor: 4.328

5.  Sertraline treatment is associated with an improvement in depression and health-related quality of life in chronic peritoneal dialysis patients.

Authors:  Huseyin Atalay; Yalcin Solak; Murat Biyik; Zeynep Biyik; Mehdi Yeksan; Faruk Uguz; Ibrahim Guney; Halil Zeki Tonbul; Suleyman Turk
Journal:  Int Urol Nephrol       Date:  2009-12-02       Impact factor: 2.370

6.  The effects of kidney-disease-related loss on long-term dialysis patients' depression and quality of life: positive affect as a mediator.

Authors:  Ramony Chan; Robert Brooks; Jonathan Erlich; Josephine Chow; Michael Suranyi
Journal:  Clin J Am Soc Nephrol       Date:  2008-11-05       Impact factor: 8.237

Review 7.  New trends on health related quality of life assessment in end-stage renal disease patients.

Authors:  Pablo Rebollo; Francisco Ortega
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

8.  Psychosocial interventions for preventing and treating depression in dialysis patients.

Authors:  Patrizia Natale; Suetonia C Palmer; Marinella Ruospo; Valeria M Saglimbene; Kannaiyan S Rabindranath; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2019-12-02

9.  Patient-reported outcome measures for life participation in peritoneal dialysis: a systematic review.

Authors:  Karine E Manera; Angela Ju; Amanda Baumgart; Elyssa Hannan; Wenjing Qiao; Martin Howell; Melissa Nataatmadja; Martin Wilkie; Fiona Loud; Daniel Schwartz; Helen Hurst; Sarbjit Vanita Jassal; Ana Figueiredo; Rajnish Mehrotra; Jenny Shen; Rachael L Morton; Thyago Moraes; Rachael Walker; Catherine Cheung; Janine F Farragher; Jonathan Craig; David W Johnson; Allison Tong
Journal:  Nephrol Dial Transplant       Date:  2021-04-26       Impact factor: 5.992

10.  Major depressive disorders in chronic hemodialysis patients in Nazareth: identification and assessment.

Authors:  Zaher Armaly; Joseph Farah; Adel Jabbour; Bishara Bisharat; Amir Abd-El Qader; Shahira Saba; Maha Zaher; Elia El Haj; Munir Hamzi; Abdalla Bowirrat
Journal:  Neuropsychiatr Dis Treat       Date:  2012-07-25       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.